CVE-2021-2110Vulnerability in the Oracle Argus Safety product of Oracle Health Sciences Applications (component: Letters).
Updated under an hour ago ()
Does this affect you?
It affects Oracle Corporation Argus Safety. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Vulnerability in the Oracle Argus Safety product of Oracle Health Sciences Applications (component: Letters). The supported version that is affected is 8.2.2. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Argus Safety. While the vulnerability is in Oracle Argus Safety, attacks may significantly impact additional products. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Argus Safety accessible data. CVSS 3.1 Base Score 5.0 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N).
- CVSS
- 5.0 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- oracle
- NVD analysis
- Modified
- Record last updated
- Sep 26, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
Oracle Corporation Argus Safety oracle:argus_safety (from the name) | 8.2.2 | CNA record |
oracle argus_safety oracle:argus_safety | 8.2.2 | NVD |
References
- https://www.oracle.com/security-alerts/cpujan2021.htmlx-refsource-misc, vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.